Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.1208
0.00 (0.00%)
At close: Aug 20, 2026
Biotricity Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.47 | 0.15 | 0.37 | 0.79 | 0.57 | 12.07 |
Short-Term Investments | 1.31 | 1.43 | 1.06 | 0.34 | 0.59 | 0.3 |
Cash & Short-Term Investments | 1.77 | 1.58 | 1.43 | 1.12 | 1.16 | 12.37 |
Cash Growth | 18.19% | 11.03% | 26.96% | -3.15% | -90.63% | 389.25% |
Accounts Receivable | 2.4 | 2.93 | 1.66 | 1.47 | 1.22 | 2.01 |
Other Receivables | - | - | - | - | - | 0.1 |
Receivables | 2.4 | 2.93 | 1.66 | 1.47 | 1.22 | 2.11 |
Inventory | 1.43 | 1.34 | 1.56 | 1.88 | 2.34 | 0.84 |
Total Current Assets | 5.6 | 5.86 | 4.64 | 4.47 | 4.72 | 15.32 |
Property, Plant & Equipment | 0.22 | 0.35 | 0.82 | 1.24 | 1.61 | 1.27 |
Other Long-Term Assets | 0.21 | 0.24 | 0.18 | 0.23 | 0.18 | 0.09 |
Total Assets | 6.02 | 6.45 | 5.64 | 5.94 | 6.51 | 16.68 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 9.3 | 4.4 | 4.6 | 5.22 | 3.44 | 1.16 |
Accrued Expenses | - | 4.53 | 3.03 | 4.37 | 1.61 | 1.44 |
Short-Term Debt | 10.97 | 11.11 | 9.62 | 9.24 | 4.77 | 1.54 |
Current Portion of Long-Term Debt | 14.83 | 14.68 | 2.4 | 2.4 | - | - |
Current Portion of Leases | 0.25 | 0.4 | 0.53 | 0.46 | 0.34 | 0.21 |
Current Unearned Revenue | - | 0.03 | 0.03 | 0.02 | - | - |
Other Current Liabilities | 1.98 | 1.98 | 0.42 | 0.99 | 1.01 | 0.52 |
Total Current Liabilities | 37.34 | 37.14 | 20.64 | 22.7 | 11.16 | 4.87 |
Long-Term Debt | 0.87 | 0.87 | 13.14 | 10.86 | 13.05 | 12.48 |
Long-Term Leases | - | - | 0.4 | 0.93 | 1.39 | 1.12 |
Total Liabilities | 38.21 | 38.01 | 34.18 | 34.48 | 25.6 | 18.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.05 |
Additional Paid-In Capital | 105.54 | 107.62 | 107.12 | 95.72 | 92.84 | 91.51 |
Retained Earnings | -143.64 | -142.57 | -139.44 | -127.5 | -112.57 | -93.04 |
Comprehensive Income & Other | 0.24 | 0.24 | 0.28 | 0.3 | -0.13 | -0.67 |
Total Common Equity | -37.84 | -34.68 | -32.01 | -31.47 | -19.85 | -2.14 |
Shareholders' Equity | -32.19 | -31.57 | -28.54 | -28.54 | -19.09 | -1.79 |
Total Liabilities & Equity | 6.02 | 6.45 | 5.64 | 5.94 | 6.51 | 16.68 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 26.93 | 27.06 | 26.09 | 23.88 | 19.55 | 15.35 |
Net Cash (Debt) | -25.16 | -25.48 | -24.67 | -22.76 | -18.39 | -2.98 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.95 | -0.93 | -1.15 | -2.53 | -2.12 | -0.39 |
Filing Date Shares Outstanding | 23.1 | 20.24 | 26.73 | 21.65 | 9.97 | 9.85 |
Total Common Shares Outstanding | 23.1 | 28.76 | 26.24 | 9.51 | 9.97 | 9.77 |
Working Capital | -31.75 | -31.28 | -16 | -18.23 | -6.44 | 10.46 |
Book Value Per Share | -1.64 | -1.21 | -1.22 | -3.31 | -1.99 | -0.22 |
Tangible Book Value | -37.84 | -34.68 | -32.01 | -31.47 | -19.85 | -2.14 |
Tangible Book Value Per Share | -1.64 | -1.21 | -1.22 | -3.31 | -1.99 | -0.22 |
Machinery | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Leasehold Improvements | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |